|
|
-
2009 IAS Conference on HIV Pathogenesis, Treatment and Prevention
July 19-22, 2009
| Cape Town, South Africa
CCO's official conference coverage of the 2009 IAS Conference on HIV Pathogenesis, Treatment and Prevention includes expert faculty analysis of key data presented on the management of HIV in developed countries, resource-constrained settings and biomedical prevention strategies as well as downloadable slides and audio podcasts summarizing clinically relevant data from this meeting.
-
In this Expert Analysis panel discussion, James G. Hakim, MBChB, MMed, MSc, FRCP, International AIDS Society President-Elect Elly Katabira, MD, and Mauro Schechter, MD, PhD, review results of the DART trial that were presented at the 2009 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
-
Andrew Carr, MBBS, MD, FRACP, FRCP; Anton L. Pozniak, MD, FRCP; and Kimberly Y. Smith, MD, MPH, discuss key studies pertaining to the management of HIV infection in developed nations presented at the 2009 International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention with a focus on the implications of those findings for clinical practice.
-
In this report on the 2009 IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sharon L. Hillier, PhD, Julio Montaner, MD, FRCPC, FCCP, and Thomas Quinn, MD, MSc, provide insight on several reports of prevention strategies and review the challenges and successes of these strategies.
-
Joseph J. Eron, Jr., MD, and Joel E. Gallant, MD, MPH, provide an overview of the most important data from the Cape Town meeting.
Latest Content
-
In this Expert Analysis panel discussion, James G. Hakim, MBChB, MMed, MSc, FRCP, International AIDS Society President-Elect Elly Katabira, MD, and Mauro Schechter, MD, PhD, review results of the DART trial that were presented at the 2009 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
Faculty: James Hakim MBChB, MMed, MSc, FRCP, Elly Katabira MD, Mauro Schechter MD, PhD
Released: 10/12/2009
-
Andrew Carr, MBBS, MD, FRACP, FRCP; Anton L. Pozniak, MD, FRCP; and Kimberly Y. Smith, MD, MPH, discuss key studies pertaining to the management of HIV infection in developed nations presented at the 2009 International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention with a focus on the implications of those findings for clinical practice.
Faculty: Andrew Carr MBBS, MD, FRACP, Anton L. Pozniak MD, FRCP, Kimberly Y. Smith MD, MPH
Released: 10/9/2009
-
In this report on the 2009 IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sharon L. Hillier, PhD, Julio Montaner, MD, FRCPC, FCCP, and Thomas Quinn, MD, MSc, provide insight on several reports of prevention strategies and review the challenges and successes of these strategies.
Faculty: Sharon L. Hillier PhD, Julio Montaner MD, FRCPC, FCCP, Thomas Quinn MD, MSc
Released: 8/26/2009
-
Joseph J. Eron, Jr., MD, and Joel E. Gallant, MD, MPH, provide an overview of the most important data from the Cape Town meeting.
Date Posted: 8/14/2009
-
A multicenter, randomized, open-label trial demonstrated the efficacy and safety of maintenance monotherapy with darunavir/ritonavir, with all 3 patients who experienced virologic failure while receiving darunavir/ritonavir monotherapy regaining HIV-1 RNA < 50 copies/mL upon reintroduction of NRTIs.
Date Posted: 7/24/2009
-
Although patients treated with IL-2 experienced significantly higher increases in CD4+ cell counts, they also had an increased risk of grade 3/4 adverse events and a greater variety of opportunistic infections compared with patients who received no treatment.
Date Posted: 7/23/2009
-
Both regimens demonstrated low virologic failure rates and comparable efficacy regardless of baseline HIV-1 RNA levels, with fewer laboratory adverse events with the unboosted regimen.
Date Posted: 7/23/2009
-
The impact of CD4+ cell count monitoring on disease progression and mortality was observed only after the first 2 years of antiretroviral therapy.
Date Posted: 7/23/2009
-
In this prospective, observational cohort conducted in Rwanda and Zambia, the rate of HIV-1 transmission in heterosexual serodiscordant couples was reduced by 79% to 90% when the index partner received antiretroviral therapy.
Date Posted: 7/23/2009
-
In a retrospective cohort analysis, patients with chronic kidney disease had significantly increased risk of acute myocardial infarction or cerebrovascular accident and were more likely to be treated with abacavir than tenofovir.
Date Posted: 7/22/2009
Conference News – Reported by NAM
|
|
|
Click here for more news reports and to learn more about NAM. |
|
Partnership Information
|
|
IAS 2009 conference organizers are using a live blog, Twitter, and Facebook to communicate with delegates attending the meeting and with those following the conference from home.
IAS 2009 Live Blog
The IAS 2009 Live blog offers updates on important developments, highlights, and links to helpful resources, and features guest bloggers with their takes on key sessions and events.
Twitter, Facebook
The IAS also provides updates through a Twitter feed (@IAS2009live) and a Facebook page (Facebook registration required).
For more information about these resources and IAS 2009 go to http://www.ias2009.org/
Clinical Care Options is the official provider of online scientific analysis of IAS 2009.
|
This coverage is produced in association with the American Academy of HIV Medicine. http://www.aahivm.org
|
http://www.aidsmap.com provides comprehensive news coverage of IAS 2009, with news reports each day and a daily summary email bulletin for those who just want the highlights of the meeting.
To view the daily news coverage, and to sign up for the daily highlights bulletin (also available in French, Spanish, Portuguese and Russian) go to http://www.aidsmap.com/ias2009 |
|
|
Jointly sponsored by USF Health and Clinical Care Options, LLC.
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|